Back to User profile » Dr Xiangshun Kong
Paper published by Dr Xiangshun Kong:
Clinical Trial Report
Eribulin plus Pyrotinib in Trastuzumab-Resistant, HER2-Positive Advanced Breast Cancer: A Single-Arm, Multicenter Phase II Trial (EPIC Trial)
Li R, Wang M, Kong X, Ma J, Qi X, Song Z
Drug Design, Development and Therapy 2025, 19:8463-8474
Published Date: 18 September 2025